Author:
Piontek Katharina,Baalmann Ann-Kristin,Feißel Annemarie,Apfelbacher Christian
Publisher
Springer Science and Business Media LLC
Reference30 articles.
1. Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF) e. V. (2023) S3-Leitlinie Atopische Dermatitis (AWMF-Registernr. 013–027. https://register.awmf.org/de/leitlinien/detail/013-027. Zugegriffen: 23. Febr. 2024
2. Axer P, Becker U (1988) § 35b. In: Sozialgesetzbuch, Fünftes Buch. Gesetzliche Krankenversicherung, S S. 371
3. Both H, Essink-Bot M‑L, Busschbach J et al (2007) Critical review of generic and dermatology-specific health-related quality of life instruments. J Invest Dermatol 127:2726–2739. https://doi.org/10.1038/sj.jid.5701142
4. Brettschneider C, Lühmann D, Raspe H (2011) Informative value of Patient Reported Outcomes (PRO) in Health Technology Assessment (HTA). GMS Health Technol Assess 7:Doc1. https://doi.org/10.3205/hta000092
5. Chren MM, Lasek RJ, Quinn LM et al (1996) Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness. J Invest Dermatol 107:707–713. https://doi.org/10.1111/1523-1747.ep12365600